Veterinary Therapeutics Market

Veterinary Therapeutics Market (Product Type - Drugs (Anti-invectives’, Anti-inflammatory, Parasiticides), Vaccines (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives (Amino Acids, Antibiotics); Animal Type - Companion Animals, Livestock Animals; Route of Administration - Oral, Parenteral, Topical; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Research & Development Activities and Commercialization of New Products to Propel Market Growth

For several decades, veterinary vaccines have played a key role in improving food security and as a result, human health. The medicine sphere wherein veterinary medicines constitute a significant share continues to evolve at a consistent pace. At present, innovations in the veterinary therapeutics market are largely made possible through advancements in technology and research & development activities. Over the past decade, a considerable amount of promising breakthroughs in the veterinary therapeutic field have paved the way for a host of specialty medicine. The significant rise in the number of pet animals worldwide, progress in surgical and medical capabilities pertaining to the treatment of animals, growing focus on improving the overall wellness of animals, significant progress in the development of new vaccines for an array of diseases, and discovery of new medication to curb the occurrence of new diseases are some of the key factors expected to influence the expansion of the veterinary therapeutics market during the forecast period.

Companies involved in the current veterinary therapeutics market landscape are actively engaged in research and development activities that have offered considerable promise. However, one of the glaring challenges that market participants are required to negotiate their way through is the evolving regulatory framework. Product development is likely to remain the cornerstone of the growth of the global veterinary therapeutics market, which is expected to reach US$ 58.5 Bn mark by the end of 2027.

veterinary therapeutics market infographic

To know the scope of our report Get a Sample on Veterinary Therapeutics Market

Breakthrough in Delivery of DNA Vaccines to Combat Avian Pathogens to Augment Market

Veterinary therapeutics have evolved at a considerable pace over the past decade, as drug developers continue to improve the overall efficacy of their products. Moreover, cost-efficiency, ease of administration, and suitability for mass vaccination are some of the other areas that have gained a great amount of consideration during the drug development phase. In recent times, DNA vaccines have offered significant promise as an ideal solution for different poultry diseases, as they have exhibited no reversion to virulence and infection. At present, DNA vaccines have started to gain a great amount of traction, as they can be deployed against an array of pathogens and are comparatively easier to develop, manufacture, and store. However, despite offering these advantages, the adoption of DNA vaccines could slow down, owing to lack of capacity to induce high immunity and lack of availability for large-scale vaccination in the current scenario.

Get a glimpse of the in-depth analysis through our Report Brochure

Vaccines and the development of new drugs will continue to progress at a consistent pace during the forecast period. Presently, in terms of product type, drugs are set to retain the majority of the share of the veterinary therapeutics market– a trend that is expected to continue during the forecast period. Although drugs will remain popular, the development of new vaccines will gain considerable momentum. DNA vaccines to address diseases in poultry are predominantly for combating bacterial, viral, and protozoan diseases. Although DNA vaccines to tackle poultry diseases have gained momentum since 1993, FDA approval for these vaccines has gathered pace only in the past decade. Clinical trials and added research and development activities will continue to boost the adoption of vaccines within the global veterinary therapeutics market in the coming years.

Companies to Rely on Inorganic Growth Strategies to Gain Ground

Companies operating in the current veterinary therapeutics market are expected to increase their market share by relying on inorganic growth strategies such as mergers & acquisitions. While expanding the product portfolio will continue to be an integral part of growth strategies for participants operating in the current market landscape, commercialization and development of new veterinary therapeutics are expected to gain momentum. For instance, in July 2019, Elanco Animal Health Incorporated announced that the company has completed the acquisition of Aratana Therapeutics. With the acquisition, Elanco could expand its product portfolio and gain the exclusive rights to manufacture, develop, and commercialize the ‘cash cow’ Galliprant. While drug development will continue to revolve around companion animals as well as livestock animals, market participants are anticipated to continue to improve the efficacy of their veterinary therapeutics during the forecast period.

veterinary therapeutics market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global veterinary therapeutics market is expected to grow at a CAGR of 5.6% during the forecast period. Some of the major factors that are likely to propel the market growth include growing demand for improved drugs, rise in the number of companion animals worldwide, improvements in surgical and medical capabilities of treatments for companion animals, development of products to combat new diseases, and growing emphasis on wellness and prevention of diseases in animals. Companies operating in the current market landscape should focus on expanding their product portfolio, investing in the development of DNA vaccines, and adopting inorganic growth strategies, including mergers & acquisitions to gain steady ground in the veterinary therapeutics market.

Veterinary Therapeutics Market: Overview

  • Veterinary therapeutics is a branch of animal healthcare that deals with prevention, treatment, and alleviation of several diseases. The veterinary therapeutics market consists of drugs for the treatment of animal diseases, vaccines for the prevention of various pathological conditions, and feed additives to maintain the overall well-being of animals by providing all the necessary nutrients required to lead a long, healthy life.
  • The drugs segment includes anti-infective, anti-inflammatory, parasiticides, and others. Different types of vaccines such as inactivated vaccine, live attenuated vaccine, recombinant vaccine, and others are used in the treatment of veterinary disorders.
  • Global demand for veterinary drugs, vaccines, and medicated feed additives to prevent, treat, and manage different animal diseases has reached an all-time high. Rapid increase in number of animal diseases, rise in companion animal ownership, and high prevalence of zoonotic diseases have fueled the demand for high quality veterinary therapeutics. According to the National Pet Owners Survey, conducted by American Pet Products Association (APPA), in 2017, around 68% of households in the U.S. owned a companion animal or pet.
  • Moreover, increase in investments in research & development of novel drugs and vaccines by private and government bodies is also expected to propel the market in the near future
  • However, low research and development (R&D) returns resulting in aging product portfolio, stringent regulatory framework, and rising concern about the use of antibiotics and growth promoters in food animals are some of the restraints of the veterinary therapeutics market

Market Segmentation: Veterinary Therapeutics Market

  • Based on product type, the global veterinary therapeutics market has been divided into drugs (anti-infective, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and medicated feed additives (amino acids, antibiotics, and others)
  • In terms of animal, the global veterinary therapeutics market has been classified into companion animal and livestock animal
  • Based on route of administration, the global veterinary therapeutics market has been divided into oral, parenteral, and topical
  • In terms of distribution channel, the global veterinary therapeutics market has been categorized into veterinary hospitals, veterinary clinic, pharmacies & drug stores, and others
  • Each of the segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with market size estimations.

Regional Overview: Veterinary Therapeutics Market

  • In terms of region, the global veterinary therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and future market value in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2017 to 2027, with their CAGRs from 2019 to 2027
  • The study also offers a list of recommendations, highlights, and useful insights of the market which would help new companies willing to enter the market and existing companies to increase market shares and decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about major players in the market
  • Leading players analyzed in the report include
    • Zoetis, Inc.
    • Merck Animal Health
    • Elanco Animal Health
    • Boehringer Ingelheim GmbH
    • Ceva Santé Animale
    • Virbac
    • Vetoquinol S.A.
    • Dechra Pharmaceuticals PLC
    • Biovac
    • The Chanelle Group
    • ImmuCell Corporation.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Veterinary Therapeutics Market - Segmentation

TMR’s study on the global veterinary therapeutics market includes information divided into four segments: product type, animal, route of administration, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global veterinary therapeutics market are discussed in detail.

Product Type

Drugs

  • Anti-infective
  • Anti-inflammatory
  • Parasiticides
  • Others

Vaccines

  • Inactivated Vaccine
  • Live Attenuated Vaccine
  • Recombinant Vaccine
  • Others

Medicated Feed Additives

  • Antibiotics
  • Amino Acids
  • Others

Animal

Companion Animal

Livestock Animal

Route of Administration

Oral

Parenteral

Topical

Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Pharmacies & Drug Stores

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of veterinary therapeutics market?

Veterinary therapeutics market is expected to reach US$ 58.5 Bn mark by the end of 2027

What is the anticipated CAGR of the veterinary therapeutics market in the forecast period?

Veterinary therapeutics market is expected to grow at a CAGR of 5.6% during 2019 - 2027

What are the key driving factors for the growth of the veterinary therapeutics market?

Veterinary therapeutics market is driven by rise in demand for high quality protein

Which region is expected to project the highest market share in the global veterinary therapeutics market?

North America accounted for a major share of the global veterinary therapeutics market and the trend is anticipated to continue during the forecast period

Who are the key players in the veterinary therapeutics market?

Key players in the global veterinary therapeutics market include Zoetis, Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim GmbH, Ceva Santé Animale

     1. Preface

         1.1. Report Scope and Market Segmentation 

         1.2. Research Highlights

     2. Assumptions and Research Methodology 

         2.1. Assumptions

         2.2. Research Methodology

     3. Executive Summary

         3.1. Global Veterinary Therapeutics Market Snapshot

     4. Market Overview

         4.1. Product Overview

         4.2. Key Industry Events

         4.3. Market Dynamics

             4.3.1. Drivers and Restraints Snapshot Analysis

             4.3.2. Drivers

             4.3.3. Restraints 

             4.3.4. Opportunities 

         4.4. Porter’s Five Forces Analysis 

         4.5. Value Chain Analysis

         4.6. Global Veterinary Therapeutics Market Outlook

     5. Market Outlook

         5.1. U.S. Pet Ownership Statistics, 2017

         5.2. Cat and Dog Annual Expenditures, 2017

         5.3. United States Pet Expenditures

     6. Global Veterinary Therapeutics Market Analysis, by Product Type

         6.1. Key Findings

         6.2. Introduction

         6.3. Global Veterinary Therapeutics Market Value Share Analysis, by Product Type

         6.4. Global Veterinary Therapeutics Market Forecast, by Product Type

             6.4.1. Drugs

             6.4.2. Vaccines

             6.4.3. Medicated Feed Additives 

         6.5. Global Veterinary Therapeutics Market Analysis, by Product Type 

         6.6. Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

             6.6.1. Anti-infective

             6.6.2. Anti-inflammatory

             6.6.3. Parasiticides

             6.6.4. Others

         6.7. Global Veterinary Therapeutics Market Analysis, by Drugs

         6.8. Global Veterinary Therapeutics Market Forecast, by Vaccines, 2017–2027

             6.8.1. Inactivated Vaccines

             6.8.2. Live Attenuated Vaccines

             6.8.3. Recombinant Vaccines

             6.8.4. Others

         6.9. Global Veterinary Therapeutics Market Analysis, by Vaccines

         6.10. Global Veterinary Medicated Feed Additives Market Forecast, by Medicated Feed Additives

             6.10.1. Antibiotics 

             6.10.2. Amino Acids

             6.10.3. Others

         6.11. Global Veterinary Medicated Feed Additives Market Analysis, by Medicated Feed Additives

         6.12. Global Veterinary Therapeutics Market Attractiveness Analysis, by Product Type

         6.13. Key Trends

     7. Global Veterinary Therapeutics Market Analysis, by Animal

         7.1. Key Findings

         7.2. Introduction 

         7.3. Global Veterinary Therapeutics Market Value Share Analysis, by Animal

         7.4. Global Veterinary Therapeutics Market Forecast, by Animal

             7.4.1. Companion Animal

             7.4.2. Livestock Animal

         7.5. Veterinary Therapeutics Market Forecast, by Animal

         7.6. Veterinary Therapeutics Market Attractiveness Analysis, by Animal

         7.7. Key Trends

     8. Veterinary Therapeutics Market Analysis, by Route of Administration

         8.1. Key Findings

         8.2. Introduction 

         8.3. Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

         8.4. Global Veterinary Therapeutics Market Value (US$ Mn) Forecast,  by Route of Administration, 2017–2027

             8.4.1. Oral

             8.4.2. Parenteral

             8.4.3. Topical

         8.5. Veterinary Therapeutics Market Forecast, by Route of Administration

         8.6. Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027

         8.7. Key Trends

     9. Global Veterinary Therapeutics Market Analysis, by Distribution Channel

         9.1. Key Findings

         9.2. Introduction 

         9.3. Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         9.4. Global Veterinary Therapeutics Market Forecast, by Distribution Channel

             9.4.1. Veterinary Hospitals

             9.4.2. Veterinary Clinics

             9.4.3. Pharmacies & Drug stores

             9.4.4. Others

         9.5. Global Veterinary Therapeutics Market Forecast, by Distribution Channel

         9.6. Global Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel

         9.7. Key Trends

     10. Global Veterinary Therapeutics Market Analysis, by Region

         10.1. Global Veterinary Therapeutics Market Snapshot, by Country

         10.2. Global Veterinary Therapeutics Market Value Share Analysis, by Region

         10.3. Global Veterinary Therapeutics Market Forecast, by Region

             10.3.1. North America

             10.3.2. Europe

             10.3.3. Asia Pacific

             10.3.4. Latin America

             10.3.5. Middle East & Africa

         10.4. Global Veterinary Therapeutics Market Attractiveness Analysis, by Region

     11. North America Veterinary Therapeutics Market Analysis

         11.1. Key Findings

         11.2. North America Veterinary Therapeutics Market Overview

         11.3. North America Veterinary Therapeutics Market Value Share Analysis, by Product Type

         11.4. North America Veterinary Therapeutics Market Forecast, by Product Type

             11.4.1. Drugs

                 11.4.1.1. Anti-infective

                 11.4.1.2. Anti-inflammatory

                 11.4.1.3. Parasiticides

                 11.4.1.4. Others

             11.4.2. Vaccines

                 11.4.2.1. Inactivated Vaccines

                 11.4.2.2. Live Attenuated Vaccines

                 11.4.2.3. Recombinant Vaccines

                 11.4.2.4. Others

             11.4.3. Medicated Feed Additives

                 11.4.3.1. Antibiotics 

                 11.4.3.2. Amino Acids

                 11.4.3.3. Others

         11.5. North America Veterinary Therapeutics Market Value Share Analysis, by Animal

         11.6. North America Veterinary Therapeutics Market Forecast, by Animal

             11.6.1. Companion Animal

             11.6.2. Livestock Animal

         11.7. North America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration

         11.8. North America Veterinary Therapeutics Market Forecast, by Route of Administration

             11.8.1. Oral

             11.8.2. Parenteral

             11.8.3. Topical

         11.9. North America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         11.10. North America Veterinary Therapeutics Market Forecast, by Distribution Channel

             11.10.1. Veterinary Hospitals

             11.10.2. Veterinary Clinics

             11.10.3. Pharmacies & Drug Stores

             11.10.4. Others

         11.11. North America Veterinary Therapeutics Market Value Share Analysis, by Country

             11.11.1. U.S.

             11.11.2. Canada

         11.12. North America Veterinary Therapeutics Market Attractiveness Analysis

         11.13. Market Trends

     12. Europe Veterinary Therapeutics Market Analysis

         12.1. Key Findings

         12.2. Europe Veterinary Therapeutics Market Overview

         12.3. Europe Veterinary Therapeutics Market Value Share Analysis, by Product Type

         12.4. Europe Veterinary Therapeutics Market Forecast, by Product Type

             12.4.1. Drugs

                 12.4.1.1. Anti-infective

                 12.4.1.2. Anti-inflammatory

                 12.4.1.3. Parasiticides

                 12.4.1.4. Others

             12.4.2. Vaccines

                 12.4.2.1. Inactivated Vaccines

                 12.4.2.2. Live Attenuated Vaccines

                 12.4.2.3. Recombinant Vaccines

                 12.4.2.4. Others

             12.4.3. Medicated Feed Additives

                 12.4.3.1. Antibiotics 

                 12.4.3.2. Amino Acids

                 12.4.3.3. Others

         12.5. Europe Veterinary Therapeutics Market Value Share Analysis, by Animal

         12.6. Europe Veterinary Therapeutics Market Forecast, by Animal

             12.6.1. Companion Animal

             12.6.2. Livestock Animal

         12.7. Europe Veterinary Therapeutics Market Value Share Analysis, by Route of Administration

         12.8. Europe Veterinary Therapeutics Market Forecast, by Route of Administration

             12.8.1. Oral

             12.8.2. Parenteral

             12.8.3. Topical

         12.9. Europe Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         12.10. Europe Veterinary Therapeutics Market Forecast, by Distribution Channel

             12.10.1. Veterinary Hospitals

             12.10.2. Veterinary Clinics

             12.10.3. Pharmacies & Drug Stores

             12.10.4. Others

         12.11. Europe Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region

             12.11.1. U.K.

             12.11.2. Germany

             12.11.3. Italy

             12.11.4. France

             12.11.5. Spain

             12.11.6. Rest of Europe

         12.12. Europe Veterinary Therapeutics Market Attractiveness Analysis

         12.13. Market Trends

     13. Asia Pacific Veterinary Therapeutics Market Analysis

         13.1. Key Findings

         13.2. Asia Pacific Veterinary Therapeutics Market Overview

         13.3. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Product Type

         13.4. Asia Pacific Veterinary Therapeutics Market Forecast, by Product Type

             13.4.1. Drugs

                 13.4.1.1. Anti-infective

                 13.4.1.2. Anti-inflammatory

                 13.4.1.3. Parasiticides

                 13.4.1.4. Others

             13.4.2. Vaccines

                 13.4.2.1. Inactivated Vaccines

                 13.4.2.2. Live Attenuated Vaccines

                 13.4.2.3. Recombinant Vaccines

                 13.4.2.4. Others

             13.4.3. Medicated Feed Additives

                 13.4.3.1. Antibiotics 

                 13.4.3.2. Amino Acids

                 13.4.3.3. Others

         13.5. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Animal

         13.6. Asia Pacific Veterinary Therapeutics Market Forecast, by Animal

             13.6.1. Companion Animal

             13.6.2. Livestock Animal

         13.7. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Route of Administration

         13.8. Asia Pacific Veterinary Therapeutics Market Forecast, by Route of Administration

             13.8.1. Oral

             13.8.2. Parenteral

             13.8.3. Topical

         13.9. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         13.10. Asia Pacific Veterinary Therapeutics Market Forecast, by Distribution Channel

             13.10.1. Veterinary Hospitals

             13.10.2. Veterinary Clinics

             13.10.3. Pharmacies & Drug Stores

             13.10.4. Others

         13.11. Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region

             13.11.1. China

             13.11.2. Japan

             13.11.3. India

             13.11.4. Australia & New Zealand

             13.11.5. Rest of Asia Pacific

         13.12. Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis

         13.13. Market Trends

     14. Latin America Veterinary Therapeutics Market Analysis

         14.1. Key Findings

         14.2. Latin America Veterinary Therapeutics Market Overview

         14.3. Latin America Veterinary Therapeutics Market Value Share Analysis, by Product Type

         14.4. Latin America Veterinary Therapeutics Market Forecast, by Product Type

             14.4.1. Drugs

                 14.4.1.1. Anti-infective

                 14.4.1.2. Anti-inflammatory

                 14.4.1.3. Parasiticides

                 14.4.1.4. Others

             14.4.2. Vaccines

                 14.4.2.1. Inactivated Vaccines

                 14.4.2.2. Live Attenuated Vaccines

                 14.4.2.3. Recombinant Vaccines

                 14.4.2.4. Others

             14.4.3. Medicated Feed Additives

                 14.4.3.1. Antibiotics 

                 14.4.3.2. Amino Acids

                 14.4.3.3. Others

         14.5. Latin America Veterinary Therapeutics Market Value Share Analysis, by Animal

         14.6. Latin America Veterinary Therapeutics Market Forecast, by Animal

             14.6.1. Companion Animal

             14.6.2. Livestock Animal

         14.7. Latin America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration

         14.8. Latin America Veterinary Therapeutics Market Forecast, by Route of Administration

             14.8.1. Oral

             14.8.2. Parenteral

             14.8.3. Topical

         14.9. Latin America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         14.10. Latin America Veterinary Therapeutics Market Forecast, by Distribution Channel

             14.10.1. Veterinary Hospitals

             14.10.2. Veterinary Clinics

             14.10.3. Pharmacies & Drug Stores

             14.10.4. Others

         14.11. Latin America Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region

             14.11.1. Brazil

             14.11.2. Mexico

             14.11.3. Rest of Latin America

         14.12. Latin America Veterinary Therapeutics Market Attractiveness Analysis

         14.13. Market Trends

     15. Middle East & Africa Veterinary Therapeutics Market Analysis

         15.1. Key Findings

         15.2. Middle East & Africa Veterinary Therapeutics Market Overview

         15.3. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Product Type

         15.4. Middle East & Africa Veterinary Therapeutics Market Forecast, by Product Type

             15.4.1. Drugs

                 15.4.1.1. Anti-infective

                 15.4.1.2. Anti-inflammatory

                 15.4.1.3. Parasiticides

                 15.4.1.4. Others

             15.4.2. Vaccines

                 15.4.2.1. Inactivated Vaccines

                 15.4.2.2. Live Attenuated Vaccines

                 15.4.2.3. Recombinant Vaccines

                 15.4.2.4. Others

             15.4.3. Medicated Feed Additives

                 15.4.3.1. Antibiotics 

                 15.4.3.2. Amino Acids

                 15.4.3.3. Others

         15.5. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Animal

         15.6. Middle East & Africa Veterinary Therapeutics Market Forecast, by Animal

             15.6.1. Companion Animal

             15.6.2. Livestock Animal

         15.7. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Route of Administration

         15.8. Middle East & Africa Veterinary Therapeutics Market Forecast, by Route of Administration

             15.8.1. Oral

             15.8.2. Parenteral

             15.8.3. Topical

         15.9. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel

         15.10. Middle East & Africa Veterinary Therapeutics Market Forecast, by Distribution Channel

             15.10.1. Veterinary Hospitals

             15.10.2. Veterinary Clinics

             15.10.3. Pharmacies & Drug Stores

             15.10.4. Others

         15.11. Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region

             15.11.1. Brazil

             15.11.2. Mexico

             15.11.3. Rest of Middle East & Africa

         15.12. Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis

         15.13. Market Trends

     16. Competition Analysis

         16.1. Global Veterinary Therapeutics Market Share Analysis, by Company

         16.2. Competition Matrix

         16.3. Company Profile

             16.3.1. Boehringer Ingelheim GmbH 

                 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.1.2. Financial Overview

                 16.3.1.3. Product Portfolio

                 16.3.1.4. SWOT Analysis

                 16.3.1.5. Strategic Overview

             16.3.2. Merck Animal Health

                 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.2.2. Financial Overview

                 16.3.2.3. Product Portfolio

                 16.3.2.4. SWOT Analysis

                 16.3.2.5. Strategic Overview

             16.3.3. Zoetis Inc. 

                 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.3.2. Financial Overview

                 16.3.3.3. Product Portfolio

                 16.3.3.4. SWOT Analysis

                 16.3.3.5. Strategic Overview

             16.3.4. Eli Lilly and Company (Elanco Animal Health) 

                 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.4.2. Financial Overview

                 16.3.4.3. Product Portfolio

                 16.3.4.4. SWOT Analysis

                 16.3.4.5. Strategic Overview

             16.3.5. Ceva Santé Animale 

                 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.5.2. Financial Overview

                 16.3.5.3. Product Portfolio

                 16.3.5.4. SWOT Analysis

                 16.3.5.5. Strategic Overview

             16.3.6. Virbac 

                 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.6.2. Financial Overview

                 16.3.6.3. Product Portfolio

                 16.3.6.4. SWOT Analysis

                 16.3.6.5. Strategic Overview

             16.3.7. Vetoquinol S.A. 

                 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.7.2. Financial Overview

                 16.3.7.3. Product Portfolio

                 16.3.7.4. SWOT Analysis

                 16.3.7.5. Strategic Overview

             16.3.8. Dechra Pharmaceuticals PLC 

                 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.8.2. Financial Overview

                 16.3.8.3. Product Portfolio

                 16.3.8.4. SWOT Analysis

                 16.3.8.5. Strategic Overview

             16.3.9. Biovac 

                 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.9.2. Financial Overview

                 16.3.9.3. Product Portfolio

                 16.3.9.4. SWOT Analysis

                 16.3.9.5. Strategic Overview

             16.3.10. The Chanelle Group 

                 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.10.2. Financial Overview

                 16.3.10.3. Product Portfolio

                 16.3.10.4. SWOT Analysis

                 16.3.10.5. Strategic Overview

             16.3.11. ImmuCell Corporation

                 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                 16.3.11.2. Financial Overview

                 16.3.11.3. Product Portfolio

                 16.3.11.4. SWOT Analysis

                 16.3.11.5. Strategic Overview

    List of Tables

    Table 01: U.S. Pet Ownership Statistics, 2017

    Table 02: Cat and Dog Annual Expenditures, 2017

    Table 03: United States Pet Expenditures (US$ Bn) 

    Table 04: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 05: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 06: Global Veterinary Therapeutics Market Forecast, by Vaccines, 2017–2027

    Table 07: Global Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 08: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027

    Table 09: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 10: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 11: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 12: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 13: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 14: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027

    Table 15: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 16: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027

    Table 17: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 18: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 19: North America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 20: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 21: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 22: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Vaccines, 2017–2027

    Table 23: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 24: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2017–2027

    Table 25: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 26: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 27: Europe Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 28: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 29: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 30: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Vaccines, 2017–2027

    Table 31: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 32: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Animal, 2017–2027

    Table 33: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 34: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 35: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 36: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 37: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 38: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027

    Table 39: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 40: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027

    Table 41: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 42: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 43: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 44: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

    Table 45: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 46: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Vaccines, 2017–2027

    Table 47: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Medicated Feed Additives, 2017–2027

    Table 48: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Animal, 2017–2027

    Table 49: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

    Table 50: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 51: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figures

    Figure 01: Global Veterinary Therapeutics Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 02: Global Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027

    Figure 03: Global Veterinary Therapeutics Market Value Share, by Product Type (2018)

    Figure 04: Global Veterinary Therapeutics Market Value Share, by Distribution Channel (2018)

    Figure 05: Global Veterinary Therapeutics Market Value Share, by Animal (2018)

    Figure 06: Global Veterinary Therapeutics Market Value Share, by Region (2018)

    Figure 07: Global Veterinary Therapeutics Market Value Share, by Route of Administration (2018)

    Figure 08: Global Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 09: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027

    Figure 10: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2027

    Figure 11: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medicated Feed Additives, 2017–2027

    Figure 12: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027

    Figure 13: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccine, 2017–2027

    Figure 14: Global Veterinary Therapeutics Market Revenue (US$ Mn), by Medicated Feed Additives, 2017–2027

    Figure 15: Veterinary Therapeutics Market Attractiveness Analysis, by Product Type, 2019-2027

    Figure 16: Global Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 17: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Companion Animal, 2017–2027

    Figure 18: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Livestock Animal, 2017–2027

    Figure 19: Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027

    Figure 20: Global Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 21: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027

    Figure 22: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017–2027

    Figure 23: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017–2027

    Figure 24: Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027

    Figure 25: Global Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 26: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals, 2017–2027

    Figure 27: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Clinics, 2017–2027

    Figure 28: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacies & Drug Stores, 2017–2027

    Figure 29: Global Veterinary Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 30: Global Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027

    Figure 31: Global Veterinary Therapeutics Market Value Share Analysis, by Region, 2018 and 2027

    Figure 32: Global Veterinary Therapeutics Market Attractiveness Analysis, by Region, 2019-2027

    Figure 33: North America Veterinary Therapeutics Market Value (US$ Mn), 2017–2027

    Figure 34: North America Veterinary Therapeutics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 35: North America Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 36: North America Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 37: North America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 38: North America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 39: North America Veterinary Therapeutics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 40: North America Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019–2027 

    Figure 41: North America Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019–2027 

    Figure 42: North America Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027 

    Figure 43: North America Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027 

    Figure 44: Europe Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027

    Figure 45: Europe Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 46: Europe Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 47: Europe Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 48: Europe Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 49: Europe Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 50: Europe Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 51: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019-2027 

    Figure 52: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027

    Figure 53: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027 

    Figure 54: Europe Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027 

    Figure 55: Asia Pacific Veterinary Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 56: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 57: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 58: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 59: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 60: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 61: Asia Pacific Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 62: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019-2027 

    Figure 63: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027 

    Figure 64: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027 

    Figure 65: Asia Pacific Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027

    Figure 66: Latin America Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027

    Figure 67: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 68: Latin America Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 69: Latin America Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 70: Latin America Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 71: Latin America Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 72: Latin America Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 73: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Product, 2019–2027

    Figure 74: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019–2027

    Figure 75: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027

    Figure 76: Latin America Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027

    Figure 77: Middle East & Africa Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2027

    Figure 78: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 79: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 80: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Animal, 2018 and 2027

    Figure 81: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027

    Figure 82: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027

    Figure 83: Middle East & Africa Veterinary Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 84: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Product Type, 2019-2027

    Figure 85: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Animal, 2019-2027

    Figure 86: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027

    Figure 87: Middle East & Africa Veterinary Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027

    Figure 88: Global Veterinary Therapeutics Market Share Analysis, by Company (2018)

Copyright © Transparency Market Research, Inc. All Rights reserved